76 related articles for article (PubMed ID: 2590915)
1. Beneficial effects of oxypurinol pretreatment in stunned, reperfused canine myocardium.
Holzgrefe HH; Gibson JK
Cardiovasc Res; 1989 Apr; 23(4):340-50. PubMed ID: 2590915
[TBL] [Abstract][Full Text] [Related]
2. Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusion.
Puett DW; Forman MB; Cates CU; Wilson BH; Hande KR; Friesinger GC; Virmani R
Circulation; 1987 Sep; 76(3):678-86. PubMed ID: 3621527
[TBL] [Abstract][Full Text] [Related]
3. The xanthine oxidase inhibitor oxypurinol does not limit infarct size in a canine model of 40 minutes of ischemia with reperfusion.
Kinsman JM; Murry CE; Richard VJ; Jennings RB; Reimer KA
J Am Coll Cardiol; 1988 Jul; 12(1):209-17. PubMed ID: 3379207
[TBL] [Abstract][Full Text] [Related]
4. The calcium antagonist nisoldipine improves the functional recovery of reperfused myocardium only when given before ischemia.
Ehring T; Böhm M; Heusch G
J Cardiovasc Pharmacol; 1992 Jul; 20(1):63-74. PubMed ID: 1383632
[TBL] [Abstract][Full Text] [Related]
5. Xanthine oxidase inhibition does not limit canine infarct size.
Werns SW; Grum CM; Ventura A; Hahn RA; Ho PP; Towner RD; Fantone JC; Schork MA; Lucchesi BR
Circulation; 1991 Mar; 83(3):995-1005. PubMed ID: 1999047
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment with the iron chelator desferrioxamine fails to provide sustained protection against myocardial ischaemia-reperfusion injury.
Reddy BR; Wynne J; Kloner RA; Przyklenk K
Cardiovasc Res; 1991 Sep; 25(9):711-8. PubMed ID: 1799904
[TBL] [Abstract][Full Text] [Related]
7. Effects of U74006F, a novel inhibitor of lipid peroxidation, in stunned reperfused canine myocardium.
Holzgrefe HH; Buchanan LV; Gibson JK
J Cardiovasc Pharmacol; 1990 Feb; 15(2):239-48. PubMed ID: 1689419
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a pathogenetic role of xanthine oxidase in the "stunned" myocardium.
Charlat MI; O'Neill PG; Egan JM; Abernethy DR; Michael LH; Myers ML; Roberts R; Bolli R
Am J Physiol; 1987 Mar; 252(3 Pt 2):H566-77. PubMed ID: 3826401
[TBL] [Abstract][Full Text] [Related]
9. Oxypurinol limits myocardial infarct size in closed chest dogs without pretreatment.
Matsuki T; Shirato C; Cohen MV; Downey JM
Can J Cardiol; 1990 Apr; 6(3):123-9. PubMed ID: 2340442
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of PEG-SOD against early coronary reperfusion injury assessed in reperfused and non-reperfused ischaemic areas of the same heart.
Kanamasa K; Ishida N; Ishikawa K
Acta Cardiol; 2001 Jun; 56(3):181-6. PubMed ID: 11471931
[TBL] [Abstract][Full Text] [Related]
11. High afterload during 10 min of regional ischaemia affects diastolic creep but not systolic function in reperfused (stunned) myocardium.
Rynning SE; Brunvand H; Birkeland S; Hexeberg E; Grong K
Acta Physiol Scand; 1996 Sep; 158(1):39-44. PubMed ID: 8876746
[TBL] [Abstract][Full Text] [Related]
12. Allopurinol: kinetics, inhibition of xanthine oxidase activity, and protective effect in ischemic-reperfused canine heart as studied by cardiac microdialysis.
Kuzmin AI; Tskitishvili OV; Serebryakova LI; Kapelko VI; Majorova IV; Medvedev OS
J Cardiovasc Pharmacol; 1995 Apr; 25(4):564-71. PubMed ID: 7596124
[TBL] [Abstract][Full Text] [Related]
13. Xamoterol recruits an inotropic reserve in the acutely failing, reperfused canine myocardium without detrimental effects on its subsequent recovery.
Schäfer S; Linder C; Heusch G
Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):206-13. PubMed ID: 2146513
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil elastase inhibitor ICI 200,880 protects against attenuation of coronary flow reserve and myocardial dysfunction following temporary coronary artery occlusion in the dog.
Mehta JL; Nichols WW; Nicolini FA; Hendricks J; Donnelly WH; Saldeen TG
Cardiovasc Res; 1994 Jul; 28(7):947-56. PubMed ID: 7954605
[TBL] [Abstract][Full Text] [Related]
15. Intracoronary magnesium is not protective against acute reperfusion injury in the regional ischaemic-reperfused dog heart.
Schlack W; Bier F; Schäfer M; Uebing A; Schäfer S; Borchard U; Thämer V
Eur J Clin Invest; 1995 Jul; 25(7):501-9. PubMed ID: 7556368
[TBL] [Abstract][Full Text] [Related]
16. Postextrasystolic potentiation does not distinguish ischaemic from stunned myocardium.
Ehring T; Heusch G
Pflugers Arch; 1991 Jun; 418(5):453-61. PubMed ID: 1891337
[TBL] [Abstract][Full Text] [Related]
17. Post-systolic shortening: a marker of potential for early recovery of acutely ischaemic myocardium in the dog.
Brown MA; Norris RM; Takayama M; White HD
Cardiovasc Res; 1987 Oct; 21(10):703-16. PubMed ID: 3440262
[TBL] [Abstract][Full Text] [Related]
18. ATP sparing effect of isoflurane during ischaemia and reperfusion of the canine heart.
Kanaya N; Kobayashi I; Nakayama M; Fujita S; Namiki A
Br J Anaesth; 1995 May; 74(5):563-8. PubMed ID: 7772433
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of free radical generation in the "stunned" myocardium in the conscious dog and identification of major differences between conscious and open-chest dogs.
Li XY; McCay PB; Zughaib M; Jeroudi MO; Triana JF; Bolli R
J Clin Invest; 1993 Aug; 92(2):1025-41. PubMed ID: 8394382
[TBL] [Abstract][Full Text] [Related]
20. Prevention of reperfusion injury in ischemic-reperfused hearts by oxypurinol and allopurinol.
LoBalsamo L; Bergsland J; Lajos P; Feldman MJ
Transpl Int; 1989 Dec; 2(4):218-22. PubMed ID: 2627264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
